Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-09-03
1998-05-12
Shah, Mukund J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
548556, 548200, 548201, 548215, 5483147, 548236, 5462784, 5462787, 544372, 544 52, C07D20712, C07D40112
Patent
active
057507066
ABSTRACT:
The compounds of formula I ##STR1## wherein R.sup.1 -R.sup.9, R.sup.15, A, X, Y, Z and n have the meaning given in the specification are active as protein kinase inhibitors and can be used as medicaments, particularly for the treatment of inflammatory skin disorders and alopecia.
REFERENCES:
Kulanthaivel et al., J. Am. Chem. Soc., 115:6452-6453 (1993).
Muller et al., Leibigs Annalen Der Chemie, Nr. 6, 651-655 (1993).
Koenig et al., Chem. Berichte, 112:2221-2226 (1980).
Barbier Pierre
Huber Isabelle
Schneider Fernand
Stadlwieser Josef
Taylor Sven
Hoffmann-La Roche Inc.
Johnston George W.
Pokras Bruce A.
Shah Mukund J.
Tramaloni Dennis P.
LandOfFree
Azepanes and their ring homologues having protein kinase inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azepanes and their ring homologues having protein kinase inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azepanes and their ring homologues having protein kinase inhibit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-980390